iRGD peptide 1 TFA

iRGD peptide 1 TFA, a paramount biomedical innovation, embodies incredible potential in cancer therapeutics. This exquisitely engineered peptide elucidates extraordinary proficiency in tumor targeting, revolutionizing drug transportation to malignant cells. Its profound impact on drug infiltration into tumor microenvironment burgeons therapeutic efficacy, effectively augmenting the potency of anticancer agents. With unparalleled benefits, iRGD peptide 1 TFA emerges as a groundbreaking solution towards combating cancer.

Online Inquiry

CAT#GR2188
M.F/FormulaC37H60F3N13O16S2
M.W/Mr.1064.08
AppearanceSolid
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Background Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be acc ...

 MSG 606 (Cyclo-[(CH2) 3CO-Gly-His-D-Phe-Arg-D-Trp-Cys(S-)]-Asp-Arg-Phe-Gly-NH2) is a potent and novel cyclic thi ...

Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...

 Catestain, a 21 amino acid fragment of chromogranin A (CgA), is divided into human CgA352-372 and bovine CgA344- ...

 Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.